Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Dexmedetomidine, Ketamine, or Midazolam in Pediatric Adenotonsillectomy
NCT07072117Completed
- Sponsor
- Zagazig University
- Start
- Feb 2023
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine, ketamine and midazolam in preoperative anxiety and laryngospasm (4 arms), sponsored by Zagazig University. Primary endpoints: Incidence and severity of post-extubation laryngospasm, Measurement of the vital signs mean blood pressure and 5 more. Started Feb 2023; status: completed.
02
Drugs
dexmedetomidineketaminemidazolam
03
Conditions
preoperative anxietylaryngospasm
Beyond the preview
Go deeper on NCT07072117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07072117.